Cargando…

What is Diabetes Remission?

Detalles Bibliográficos
Autores principales:	Holst, Jens J., Madsbad, Sten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947138/ https://www.ncbi.nlm.nih.gov/pubmed/33609265 http://dx.doi.org/10.1007/s13300-021-01032-y

Ejemplares similares

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans
por: Asmar, Meena, et al.
Publicado: (2010)

Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion: A case report
por: Dirksen, Carsten, et al.
Publicado: (2010)

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss()
por: Holst, Jens Juul, et al.
Publicado: (2018)

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report
por: Knop, Filip K, et al.
Publicado: (2014)

Addressing upstream determinants of health in Germany’s new global health strategy: recommendations from the German Platform for Global Health
por: Holst, Jens
Publicado: (2019)

Beyond Response: Aiming for Quality Remission in Depression
por: Kennedy, Sidney H.
Publicado: (2022)

Survival, remission, and quality of life in diabetic cats
por: Rothlin‐Zachrisson, Ninni, et al.
Publicado: (2023)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2019)

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery
por: Li, Qing-Run, et al.
Publicado: (2018)

Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men
por: Asmar, Ali, et al.
Publicado: (2017)

GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report
por: Iepsen, Eva W., et al.
Publicado: (2020)

Neural Networks, Cognition, and Diabetes: What Is the Connection?
por: Jones, David T.
Publicado: (2012)

β-cell dedifferentiation in diabetes is important, but what is it?
por: Weir, Gordon C, et al.
Publicado: (2013)

What’s in a Name? Redefining Type 2 Diabetes Remission
por: Kalra, Sanjay, et al.
Publicado: (2021)

What is the ideal biological marker in diagnosis of diabetic neuropathies?
por: Jin, Heung Yong, et al.
Publicado: (2013)

The Virchow Prize: cementing commodification, coloniality and biomedical reductionism in global health?
por: Holst, Jens, et al.
Publicado: (2023)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

Fractionated free fatty acids and their relation to diabetes status after Roux‐en‐Y gastric bypass: A cohort study
por: Eriksen, Freja, et al.
Publicado: (2021)

Early antiretroviral treatment of infants to attain HIV remission: Not just a matter of timing
por: Faye, Albert
Publicado: (2020)

The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults
por: Nilsson, Malin, et al.
Publicado: (2019)

Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
por: Madsbad, Sten
Publicado: (2015)

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2022)

A Summary of 2018 and What Lies Ahead for Diabetes Therapy in 2019
por: Evans, Marc, et al.
Publicado: (2019)

Type 1 diabetes: what is the role of autoimmunity in β cell death?
por: Donath, Marc Y.
Publicado: (2022)

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study
por: Dejgaard, Thomas Fremming, et al.
Publicado: (2015)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial
por: Thirumathyam, Roopameera, et al.
Publicado: (2022)

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2013)

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
por: Leiter, Lawrence A., et al.
Publicado: (2019)

Targeting B-cells Mitigates Autoimmune Diabetes in NOD Mice: What Is Plan B?
por: Smith, Susan H., et al.
Publicado: (2009)

Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease
por: Anholm, Christian, et al.
Publicado: (2019)

What Is Culinary Medicine and What Does It Do?
por: La Puma, John
Publicado: (2016)

Sorting It Out: What JNC 8 Is and What It Is Not
por: Finks, Shannon, et al.
Publicado: (2015)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
por: Czupryniak, Leszek, et al.
Publicado: (2021)

Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose?
por: Liang, Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p72tpdhpkgf6jeq2mr5q6rmj1p